Luisa Alejandra Penagos Ochoa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luisa Alejandra Penagos Ochoa has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Cesar Augusto Flores Dueñas
Instituto de Investigaciones en Ciencias Veterinarias, Universidad Autónoma de Baja California
1 shared publication - Javier Ignacio Soto Espinoza
Universidad San Sebastián, Medical Department, Santiago de Chile, Chile
1 shared publication - Jessica Samantha Rea Fernández
Universidad de Cuenca, Ecuador
1 shared publication - Melina Carlos Tovar
Instituto mexicano del seguro social, Internal Medicine. Torreón, México
1 shared publication - Mishelle Estefania Garces Lopez
EMI FALCK, Medical Department, Quito, Ecuador
1 shared publication - Mitchell Walter Carbajal Alvarado
Cefies Q, Medical Technology, Lima Perú
1 shared publication
Latest Publications
- Open Access
- 1 August 2025
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 5, 1955
Impact of Extracorporeal Membrane Oxygenation (ECMO) in Patients with Refractory Cardiogenic Shock: Analysis of Mortality and Hemodynamic Recovery - A Systematic Review
Introduction: Extracorporeal membrane oxygenation (ECMO) is an advanced life support for critically ill patients with refractory cardiogenic shock. However, evidence on its impact on mortality, hemodynamic recovery, and complications remains heterogeneous. This review aims to systematically evaluate ECMO’s impact on mortality and hemodynamic recovery in adult patients with refractory cardiogenic shock, addressing gaps and variations in existing literature.Material and Methods: This systematic review followed PRISMA guidelines. Databases searched were PubMed, Cochrane Library, and Google Scholar. Two reviewers independently selected studies, extracted data, and assessed quality using the Newcastle–Ottawa Scale. Findings were synthesized narratively due to study heterogeneity.Results: Mortality rates ranged widely from 33 to 75%, reflecting differences in patient populations and timing of ECMO initiation. Early ECMO initiation within less than one hour of shock onset was associated with a 47 percent reduction in mortality risk. In-hospital mortality was approximately 40%, increasing to nearly 60% at one-year follow-up. Success rates for weaning patients off ECMO varied between 53% and 88%. Hemodynamic improvements following ECMO support included increased blood pressure, improved left ventricular ejection fraction, and decreased serum lactate levels. Complications were frequent and diverse, predominantly bleeding, stroke, renal failure, and limb ischemia. Bleeding complications are strongly correlated with mortality.Conclusions: ECMO provides crucial circulatory support in refractory cardiogenic shock, improving hemodynamic parameters but with persistently high mortality and complication rates. Early initiation and careful patient selection are vital for optimizing outcomes, underscoring the need for multidisciplinary management and further high-quality prospective studies.
- 1 August 2025
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 5, 1955
Open AccessImpact of Extracorporeal Membrane Oxygenation (ECMO) in Patients with Refractory Cardiogenic Shock: Analysis of Mortality and Hemodynamic Recovery - A Systematic Review
Introduction: Extracorporeal membrane oxygenation (ECMO) is an advanced life support for critically ill patients with refractory cardiogenic shock. However, evidence on its impact on mortality, hemodynamic recovery, and complications remains heterogeneous. This review aims to systematically evaluate ECMO’s impact on mortality and hemodynamic recovery in adult patients with refractory cardiogenic shock, addressing gaps and variations in existing literature.Material and Methods: This systematic review followed PRISMA guidelines. Databases searched were PubMed, Cochrane Library, and Google Scholar. Two reviewers independently selected studies, extracted data, and assessed quality using the Newcastle–Ottawa Scale. Findings were synthesized narratively due to study heterogeneity.Results: Mortality rates ranged widely from 33 to 75%, reflecting differences in patient populations and timing of ECMO initiation. Early ECMO initiation within less than one hour of shock onset was associated with a 47 percent reduction in mortality risk. In-hospital mortality was approximately 40%, increasing to nearly 60% at one-year follow-up. Success rates for weaning patients off ECMO varied between 53% and 88%. Hemodynamic improvements following ECMO support included increased blood pressure, improved left ventricular ejection fraction, and decreased serum lactate levels. Complications were frequent and diverse, predominantly bleeding, stroke, renal failure, and limb ischemia. Bleeding complications are strongly correlated with mortality.Conclusions: ECMO provides crucial circulatory support in refractory cardiogenic shock, improving hemodynamic parameters but with persistently high mortality and complication rates. Early initiation and careful patient selection are vital for optimizing outcomes, underscoring the need for multidisciplinary management and further high-quality prospective studies.